Table 1.
Demographic and neuropathological characteristics of all human post-mortem subjects
| BBN | SD | Clinical diagnosis | Braak stage | Thal phase | Age (years) | Sex | PMI (h) | Lewy body? | Study used |
|---|---|---|---|---|---|---|---|---|---|
| 001.35138 | SD042/18 | Control | 0 | 1 | 73 | F | 74 | N | Figure 1 |
| 001.34150 | SD030/18 | Control | 0 | 0 | 63 | M | 115 | N | Figure 1 |
| 001.30178 | SD024/17 | Control | 0 | 0 | 72 | M | 60 | N | Figure 1 |
| 001.35420 | SD015/19 | Control | I | 0 | 82 | F | 114 | N | Figure 1 |
| 001.35215 | SD008/19 | Control | I | 0 | 82 | M | 40 | N | Figure 1 |
| 001.31504 | SD046/17 | Control | I | 0 | 65 | F | 76 | N | Figure 1 |
| 001.31503 | SD045/17 | Control | I | 1 | 57 | F | 73 | N | Figure 1 |
| 001.28402 | SD051/15 | Control | I | 2 | 79 | M | 49 | N | Figure 1 |
| 001.28794 | SD018/16 | Control | I | 0 | 79 | F | 72 | N | Figure 1 |
| 001.30208 | SD025/17 | Control | I | 1 | 73 | M | 66 | N | Figure 1 |
| 001.29528 | SD045/16 | Control | III | 5 | 93 | F | 31 | N | Figure 1 |
| 001.28411 | SD006/16 | Control | III | 2 | 88 | F | 65 | N | Figure 1 |
| 001.26499 | SD037/15 | Control | III | 1 | 81 | F | 59 | N | Figure 1 |
| 001.26491 | SD023/15 | Control | III | 2 | 77 | M | 27 | Y subcortical | Figure 1 |
| 001.20994 | SD017/14 | Control | III | 4 | 75 | M | 58 | N | Figure 1 |
| 001.19600 | SD045/13 | Control | III | 3 | 85 | F | 36 | N | Figure 1 |
| 001.32820 | SD008/18 | Control | IV | 4 | 69 | F | 94 | N | Figure 1 |
| 001.28405 | SD052/15 | Control | IV | 2 | 84 | M | 83 | N | Figure 1 |
| 001.26492 | SD013/15 | Control | IV | 4 | 74 | F | 71 | N | Figure 1 |
| 001.24323 | SD050/14 | Control | IV | 4 | 67 | M | 103 | N | Figure 1 |
| 001.35183 | SD005/19 | AD | VI | 5 | 74 | M | 75 | Y cortical LBD | Figure 1 |
| 001.35096 | SD037/18 | AD | VI | 5 | 72 | M | 103 | N | Figure 1 |
| 001.33698 | SD021/18 | AD | VI | 5 | 90 | F | 76 | Y brainstem | Figure 1 |
| 001.33636 | SD017/18 | AD | VI | 5 | 93 | M | 43 | Y brainstem | Figure 1 |
| 001.32929 | SD012/18 | AD | VI | 5 | 85 | F | 80 | N | Figure 1 |
| 001.30883 | SD034/17 | AD | VI | 5 | 61 | F | 69 | N | Figure 1 |
| 001.29911 | SD014/17 | AD | VI | 5 | 66 | M | 52 | Y cortical LBD | Figure 1 |
| 001.29521 | SD035/16 | AD | VI | 5 | 95 | M | 96 | N | Figure 1 |
| 001.26500 | SD039/15 | AD | VI | 5 | 81 | M | 83 | N | Figure 1 |
| 001.24668 | SD058/14 | AD | VI | 5 | 96 | F | 61 | N | Figure 1 |
| 001.19686 | SD063/13 | Control | I | 1 | 77 | F | 75 | N | Figure 2 |
| 001.26495 | SD024/15 | Control | I | 0 | 78 | M | 78 | N | Figure 2 |
| 001.28406 | SD001/16 | Control | II | 2 | 79 | M | 72 | N | Figure 2 |
| 001.36135 | SD012/20 | Control | II | 1 | 84 | F | 30 | N | Figure 2 |
| 001.28793 | SD017/16 | Control | II | 1 | 79 | F | 72 | N | Figure 2 |
| 001.26718 | SD040/15 | AD | VI | 5 | 78 | M | 74 | N | Figure 2 |
| 001.28771 | SD010/16 | AD | VI | 5 | 85 | M | 91 | N | Figure 2 |
| 001.30973 | SD039/17 | AD | VI | 5 | 89 | F | 96 | N | Figure 2 |
| 001.32929 | SD012/18 | AD | VI | 5 | 85 | F | 80 | N | Figure 2 |
| 001.35182 | SD004/19 | AD | VI | 5 | 66 | M | 49 | N | Figure 2 |
| 001.19686 | SD063/13 | Control | I | 1 | 77 | F | 75 | N | Figure 3 |
| 001.26495 | SD024/15 | Control | I | 0 | 78 | M | 78 | N | Figure 3 |
| 001.29082 | SD031/16 | Control | III | 5 | 79 | F | 80 | N | Figure 3 |
| 001.35181 | SD003/19 | Control | II | 2 | 82 | M | 49 | N | Figure 3 |
| 001.28794 | SD018/16 | Control | I | 0 | 79 | F | 72 | N | Figure 3 |
| 001.24527 | SD056/14 | AD | V | 4 | 81 | M | 74 | N | Figure 3 |
| 001.28771 | SD010/16 | AD | VI | 5 | 85 | M | 91 | N | Figure 3 |
| 001.29695 | SD004/17 | AD | VI | 5 | 86 | M | 72 | Y limbic | Figure 3 |
| 001.30973 | SD039/17 | AD | VI | 5 | 89 | F | 96 | N | Figure 3 |
| 001.28410 | SD005/16 | AD | V | 5 | 62 | F | 109 | N | Figure 3 |
AD Alzheimer’s disease, BBN Medical Research Council Brain Bank Number, SD Edinburgh Brain Bank Number, PMI postmortem interval